Paul L. Chariou
0000-0002-7115-3878
University of California
2 papers found
Refreshing results…
Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12
Tumour-targeted interleukin-12 and entinostat combination therapy improves cancer survival by reprogramming the tumour immune cell landscape
Missing publications? Search for publications with a matching author name.